Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Orthofix Medical (OFIX) Equity Average (2016 - 2025)

Orthofix Medical (OFIX) has disclosed Equity Average for 15 consecutive years, with $446.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Equity Average fell 13.27% year-over-year to $446.3 million, compared with a TTM value of $446.3 million through Dec 2025, down 13.27%, and an annual FY2025 reading of $476.6 million, down 13.49% over the prior year.
  • Equity Average was $446.3 million for Q4 2025 at Orthofix Medical, down from $450.4 million in the prior quarter.
  • Across five years, Equity Average topped out at $652.1 million in Q2 2023 and bottomed at $335.2 million in Q4 2022.
  • Average Equity Average over 5 years is $459.7 million, with a median of $454.4 million recorded in 2025.
  • The sharpest move saw Equity Average soared 92.49% in 2023, then decreased 17.89% in 2025.
  • Year by year, Equity Average stood at $350.9 million in 2021, then decreased by 4.47% to $335.2 million in 2022, then soared by 81.12% to $607.1 million in 2023, then decreased by 15.25% to $514.5 million in 2024, then fell by 13.27% to $446.3 million in 2025.
  • Business Quant data shows Equity Average for OFIX at $446.3 million in Q4 2025, $450.4 million in Q3 2025, and $458.3 million in Q2 2025.